{"slideshow_credits": null, "snippet": "The drug maker\u2019s acting C.E.O., Howard B. Schiller, said it was uncertain when J. Michael Pearson, who Valeant said had been hospitalized with severe pneumonia, would be back.", "abstract": "Valeant Pharmaceuticals interim chief executive Howard B Schiller says it is unclear when J Michael Pearson will return as chief; Pearson is recovering from pneumonia.", "section_name": "Business Day", "print_page": "4", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK"}, "web_url": "http://www.nytimes.com/2016/01/14/business/ailing-valeant-chiefs-return-date-is-uncertain.html", "lead_paragraph": "The drug maker\u2019s acting C.E.O., Howard B. Schiller, said it was uncertain when J. Michael Pearson, who Valeant said had been hospitalized with severe pneumonia, would be back.", "headline": {"main": "Ailing Valeant Chief&#8217;s Return Date Is Uncertain ", "print_headline": "Valeant Official Says Chief&#8217;s Return Date Is Uncertain "}, "_id": "5696f7a038f0d865e6c34986", "word_count": "475", "multimedia": [{"height": 126, "url": "images/2016/01/14/business/14valeant-web/14valeant-web-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2016/01/14/business/14valeant-web/14valeant-web-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 431, "url": "images/2016/01/14/business/14valeant-web/14valeant-web-articleLarge.jpg", "legacy": {"xlarge": "images/2016/01/14/business/14valeant-web/14valeant-web-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "431"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2016/01/14/business/14valeant-web/14valeant-web-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/01/14/business/14valeant-web/14valeant-web-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2016-01-14T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "persons", "value": "Pearson, John Michael (1959- )", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Appointments and Executive Changes", "is_major": "N", "rank": "3"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "4"}, {"name": "persons", "value": "Schiller, Howard B", "is_major": "N", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "News"}